Savant Capital LLC Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Savant Capital LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,803 shares of the medical equipment provider’s stock after buying an additional 1,030 shares during the period. Savant Capital LLC’s holdings in Intuitive Surgical were worth $3,551,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of ISRG. Martin Capital Advisors LLP raised its stake in shares of Intuitive Surgical by 4.3% during the fourth quarter. Martin Capital Advisors LLP now owns 20,206 shares of the medical equipment provider’s stock valued at $10,547,000 after acquiring an additional 825 shares in the last quarter. Bank of Stockton raised its stake in shares of Intuitive Surgical by 13.5% during the fourth quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock valued at $606,000 after acquiring an additional 138 shares in the last quarter. Focused Wealth Management Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $218,000. 17 Capital Partners LLC raised its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. 17 Capital Partners LLC now owns 1,851 shares of the medical equipment provider’s stock valued at $966,000 after acquiring an additional 35 shares in the last quarter. Finally, Kestra Private Wealth Services LLC raised its stake in shares of Intuitive Surgical by 9.1% during the fourth quarter. Kestra Private Wealth Services LLC now owns 45,518 shares of the medical equipment provider’s stock valued at $23,759,000 after acquiring an additional 3,809 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 0.7 %

NASDAQ ISRG opened at $591.65 on Wednesday. The firm has a market capitalization of $210.73 billion, a P/E ratio of 92.30, a P/E/G ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm’s fifty day simple moving average is $555.91 and its two-hundred day simple moving average is $515.92.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on ISRG shares. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective for the company. Finally, Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.